The role of Vitamin C in managing type 2 diabetes: Vitamin C, Thiazolidinediones and their combined effect onAdiponecti
Recruiting
- Conditions
- Type 2 diabetesMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12611000488909
- Lead Sponsor
- Princess Alexandra Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Female or male participants between the ages of 18 and 70 with non insulin dependent type 2 diabetes under TZD treatment (either rosiglitazone 4 – 8 mg or piogitazone greater than or equal 30 mg) with or without metformin.
HbA1C level 7 – 8.5 %.
Participant on stable diabetic therapy for three months prior to the intervention.
Exclusion Criteria
HbA1C level greater than 8.5 %
Participants must have a stable body weight (< 5% selfreported weight loss/gain) within last 3 months prior to enrolment.
Participants taking iron supplements.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase in high molecular weight adiponectin assessed using a blood test and subsequent laboratory analysis of the sample.[At the start of the trial, fortnightly after each increase in Vitamin C dosage and then a fortnight after the final Vitamin C dosage is complete.]
- Secondary Outcome Measures
Name Time Method il[Nil]